Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Cancer Tumor Profiling Market Size Growth Rate by Type (2014-2025) 1.4.2 Next-generation Sequencing (NGS) 1.4.3 Polymerase Chain Reaction (PCR) 1.4.4 Immunohistochemistry (IHC) 1.4.5 In Situ Hybridization (ISH) 1.4.6 Microarray 1.4.7 Others 1.5 Market by Application 1.5.1 Global Cancer Tumor Profiling Market Share by Application (2014-2025) 1.5.2 Personalized Medicine 1.5.3 Diagnostics 1.5.4 Biomarker Discovery 1.5.5 Prognostics 1.5.6 Research Applications 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Cancer Tumor Profiling Market Size 2.2 Cancer Tumor Profiling Growth Trends by Regions 2.2.1 Cancer Tumor Profiling Market Size by Regions (2014-2025) 2.2.2 Cancer Tumor Profiling Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Cancer Tumor Profiling Market Size by Manufacturers 3.1.1 Global Cancer Tumor Profiling Revenue by Manufacturers (2014-2019) 3.1.2 Global Cancer Tumor Profiling Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Cancer Tumor Profiling Market Concentration Ratio (CR5 and HHI) 3.2 Cancer Tumor Profiling Key Players Head office and Area Served 3.3 Key Players Cancer Tumor Profiling Product/Solution/Service 3.4 Date of Enter into Cancer Tumor Profiling Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Cancer Tumor Profiling Market Size by Type (2014-2019) 4.2 Global Cancer Tumor Profiling Market Size by Application (2014-2019) 5 United States 5.1 United States Cancer Tumor Profiling Market Size (2014-2019) 5.2 Cancer Tumor Profiling Key Players in United States 5.3 United States Cancer Tumor Profiling Market Size by Type 5.4 United States Cancer Tumor Profiling Market Size by Application 6 Europe 6.1 Europe Cancer Tumor Profiling Market Size (2014-2019) 6.2 Cancer Tumor Profiling Key Players in Europe 6.3 Europe Cancer Tumor Profiling Market Size by Type 6.4 Europe Cancer Tumor Profiling Market Size by Application 7 China 7.1 China Cancer Tumor Profiling Market Size (2014-2019) 7.2 Cancer Tumor Profiling Key Players in China 7.3 China Cancer Tumor Profiling Market Size by Type 7.4 China Cancer Tumor Profiling Market Size by Application 8 Japan 8.1 Japan Cancer Tumor Profiling Market Size (2014-2019) 8.2 Cancer Tumor Profiling Key Players in Japan 8.3 Japan Cancer Tumor Profiling Market Size by Type 8.4 Japan Cancer Tumor Profiling Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Cancer Tumor Profiling Market Size (2014-2019) 9.2 Cancer Tumor Profiling Key Players in Southeast Asia 9.3 Southeast Asia Cancer Tumor Profiling Market Size by Type 9.4 Southeast Asia Cancer Tumor Profiling Market Size by Application 10 India 10.1 India Cancer Tumor Profiling Market Size (2014-2019) 10.2 Cancer Tumor Profiling Key Players in India 10.3 India Cancer Tumor Profiling Market Size by Type 10.4 India Cancer Tumor Profiling Market Size by Application 11 Central & South America 11.1 Central & South America Cancer Tumor Profiling Market Size (2014-2019) 11.2 Cancer Tumor Profiling Key Players in Central & South America 11.3 Central & South America Cancer Tumor Profiling Market Size by Type 11.4 Central & South America Cancer Tumor Profiling Market Size by Application 12 International Players Profiles 12.1 Qiagen N.V. 12.1.1 Qiagen N.V. Company Details 12.1.2 Company Description and Business Overview 12.1.3 Cancer Tumor Profiling Introduction 12.1.4 Qiagen N.V. Revenue in Cancer Tumor Profiling Business (2014-2019) 12.1.5 Qiagen N.V. Recent Development 12.2 Roche Molecular Systems Inc. 12.2.1 Roche Molecular Systems Inc. Company Details 12.2.2 Company Description and Business Overview 12.2.3 Cancer Tumor Profiling Introduction 12.2.4 Roche Molecular Systems Inc. Revenue in Cancer Tumor Profiling Business (2014-2019) 12.2.5 Roche Molecular Systems Inc. Recent Development 12.3 Abott Molecular 12.3.1 Abott Molecular Company Details 12.3.2 Company Description and Business Overview 12.3.3 Cancer Tumor Profiling Introduction 12.3.4 Abott Molecular Revenue in Cancer Tumor Profiling Business (2014-2019) 12.3.5 Abott Molecular Recent Development 12.4 Illumina Inc. 12.4.1 Illumina Inc. Company Details 12.4.2 Company Description and Business Overview 12.4.3 Cancer Tumor Profiling Introduction 12.4.4 Illumina Inc. Revenue in Cancer Tumor Profiling Business (2014-2019) 12.4.5 Illumina Inc. Recent Development 12.5 NeoGenomics Laboratories 12.5.1 NeoGenomics Laboratories Company Details 12.5.2 Company Description and Business Overview 12.5.3 Cancer Tumor Profiling Introduction 12.5.4 NeoGenomics Laboratories Revenue in Cancer Tumor Profiling Business (2014-2019) 12.5.5 NeoGenomics Laboratories Recent Development 12.6 HTG Molecular Diagnostic 12.6.1 HTG Molecular Diagnostic Company Details 12.6.2 Company Description and Business Overview 12.6.3 Cancer Tumor Profiling Introduction 12.6.4 HTG Molecular Diagnostic Revenue in Cancer Tumor Profiling Business (2014-2019) 12.6.5 HTG Molecular Diagnostic Recent Development 12.7 Genomic Health Inc. 12.7.1 Genomic Health Inc. Company Details 12.7.2 Company Description and Business Overview 12.7.3 Cancer Tumor Profiling Introduction 12.7.4 Genomic Health Inc. Revenue in Cancer Tumor Profiling Business (2014-2019) 12.7.5 Genomic Health Inc. Recent Development 12.8 Hologic Gen-Probe 12.8.1 Hologic Gen-Probe Company Details 12.8.2 Company Description and Business Overview 12.8.3 Cancer Tumor Profiling Introduction 12.8.4 Hologic Gen-Probe Revenue in Cancer Tumor Profiling Business (2014-2019) 12.8.5 Hologic Gen-Probe Recent Development 12.9 BD Biosciences 12.9.1 BD Biosciences Company Details 12.9.2 Company Description and Business Overview 12.9.3 Cancer Tumor Profiling Introduction 12.9.4 BD Biosciences Revenue in Cancer Tumor Profiling Business (2014-2019) 12.9.5 BD Biosciences Recent Development 12.10 Siemens Healthineers 12.10.1 Siemens Healthineers Company Details 12.10.2 Company Description and Business Overview 12.10.3 Cancer Tumor Profiling Introduction 12.10.4 Siemens Healthineers Revenue in Cancer Tumor Profiling Business (2014-2019) 12.10.5 Siemens Healthineers Recent Development 12.11 Claris Life Sciences 12.12 Personal Genome Diagnostics, Inc. 12.13 Perthera, Inc. 12.14 Foundation Medicine, Inc 12.15 V., Strand 12.16 ApoCell 12.17 Contextual Genomics 12.18 Agendia 12.19 GenScript 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Cancer Tumor Profiling Key Market Segments Table Key Players Cancer Tumor Profiling Covered Table Global Cancer Tumor Profiling Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Cancer Tumor Profiling Market Size Market Share by Type 2014-2025 Figure Next-generation Sequencing (NGS) Figures Table Key Players of Next-generation Sequencing (NGS) Figure Polymerase Chain Reaction (PCR) Figures Table Key Players of Polymerase Chain Reaction (PCR) Figure Immunohistochemistry (IHC) Figures Table Key Players of Immunohistochemistry (IHC) Figure In Situ Hybridization (ISH) Figures Table Key Players of In Situ Hybridization (ISH) Figure Microarray Figures Table Key Players of Microarray Figure Others Figures Table Key Players of Others Table Global Cancer Tumor Profiling Market Size Growth by Application 2014-2025 (Million US$) Figure Personalized Medicine Case Studies Figure Diagnostics Case Studies Figure Biomarker Discovery Case Studies Figure Prognostics Case Studies Figure Research Applications Case Studies Figure Cancer Tumor Profiling Report Years Considered Table Global Cancer Tumor Profiling Market Size 2014-2025 (Million US$) Figure Global Cancer Tumor Profiling Market Size and Growth Rate 2014-2025 (Million US$) Table Global Cancer Tumor Profiling Market Size by Regions 2014-2025 (Million US$) Table Global Cancer Tumor Profiling Market Size by Regions 2014-2019 (Million US$) Table Global Cancer Tumor Profiling Market Share by Regions 2014-2019 Figure Global Cancer Tumor Profiling Market Share by Regions 2014-2019 Figure Global Cancer Tumor Profiling Market Share by Regions 2019 Table Market Top Trends Table Global Cancer Tumor Profiling Revenue by Manufacturers (2014-2019) (Million US$) Table Global Cancer Tumor Profiling Market Share by Manufacturers (2014-2019) Figure Global Cancer Tumor Profiling Market Share by Manufacturers in 2018 Table Global Cancer Tumor Profiling Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Cancer Tumor Profiling Product/Solution/Service Table Date of Enter into Cancer Tumor Profiling Market Table Mergers & Acquisitions, Expansion Plans Table Global Cancer Tumor Profiling Market Size by Type (2014-2019) (Million US$) Table Global Cancer Tumor Profiling Market Size Share by Type (2014-2019) Figure Global Cancer Tumor Profiling Market Size Market Share by Type (2014-2019) Table Global Cancer Tumor Profiling Market Size by Application (2014-2019) (Million US$) Table Global Cancer Tumor Profiling Market Size Share by Application (2014-2019) Figure Global Cancer Tumor Profiling Market Size Market Share by Application (2014-2019) Figure Global Cancer Tumor Profiling Revenue Market Share by Application in 2018 Figure United States Cancer Tumor Profiling Market Size 2014-2019 (Million US$) Table United States Key Players Cancer Tumor Profiling Revenue (2018-2019) (Million US$) Table United States Key Players Cancer Tumor Profiling Market Share (2018-2019) Table United States Cancer Tumor Profiling Market Size by Type (2014-2019) (Million US$) Table United States Cancer Tumor Profiling Market Share by Type (2014-2019) Table United States Cancer Tumor Profiling Market Size by Application (2014-2019) (Million US$) Table United States Cancer Tumor Profiling Market Share by Application (2014-2019) Figure Europe Cancer Tumor Profiling Market Size 2014-2019 (Million US$) Table Europe Key Players Cancer Tumor Profiling Revenue (2018-2019) (Million US$) Table Europe Key Players Cancer Tumor Profiling Market Share (2018-2019) Table Europe Cancer Tumor Profiling Market Size by Type (2014-2019) (Million US$) Table Europe Cancer Tumor Profiling Market Share by Type (2014-2019) Table Europe Cancer Tumor Profiling Market Size by Application (2014-2019) (Million US$) Table Europe Cancer Tumor Profiling Market Share by Application (2014-2019) Figure China Cancer Tumor Profiling Market Size 2014-2019 (Million US$) Table China Key Players Cancer Tumor Profiling Revenue (2018-2019) (Million US$) Table China Key Players Cancer Tumor Profiling Market Share (2018-2019) Table China Cancer Tumor Profiling Market Size by Type (2014-20189) (Million US$) Table China Cancer Tumor Profiling Market Share by Type (2014-2019) Table China Cancer Tumor Profiling Market Size by Application (2014-2019) (Million US$) Table China Cancer Tumor Profiling Market Share by Application (2014-2019) Figure Japan Cancer Tumor Profiling Market Size 2014-2019 (Million US$) Table Japan Key Players Cancer Tumor Profiling Revenue (2018-2019) (Million US$) Table Japan Key Players Cancer Tumor Profiling Market Share (2018-2019) Table Japan Cancer Tumor Profiling Market Size by Type (2014-2019) (Million US$) Table Japan Cancer Tumor Profiling Market Share by Type (2014-2019) Table Japan Cancer Tumor Profiling Market Size by Application (2014-2019) (Million US$) Table Japan Cancer Tumor Profiling Market Share by Application (2014-2019) Figure Southeast Asia Cancer Tumor Profiling Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Cancer Tumor Profiling Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Cancer Tumor Profiling Market Share (2018-2019) Table Southeast Asia Cancer Tumor Profiling Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Cancer Tumor Profiling Market Share by Type (2014-2019) Table Southeast Asia Cancer Tumor Profiling Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Cancer Tumor Profiling Market Share by Application (2014-2019) Figure India Cancer Tumor Profiling Market Size 2014-2019 (Million US$) Table India Key Players Cancer Tumor Profiling Revenue (2018-2019) (Million US$) Table India Key Players Cancer Tumor Profiling Market Share (2018-2019) Table India Cancer Tumor Profiling Market Size by Type (2014-2019) (Million US$) Table India Cancer Tumor Profiling Market Share by Type (2014-2019) Table India Cancer Tumor Profiling Market Size by Application (2014-2019) (Million US$) Table India Cancer Tumor Profiling Market Share by Application (2014-2019) Figure Central & South America Cancer Tumor Profiling Market Size 2014-2019 (Million US$) Table Central & South America Key Players Cancer Tumor Profiling Revenue (2018-2019) (Million US$) Table Central & South America Key Players Cancer Tumor Profiling Market Share (2018-2019) Table Central & South America Cancer Tumor Profiling Market Size by Type (2014-2019) (Million US$) Table Central & South America Cancer Tumor Profiling Market Share by Type (2014-2019) Table Central & South America Cancer Tumor Profiling Market Size by Application (2014-2019) (Million US$) Table Central & South America Cancer Tumor Profiling Market Share by Application (2014-2019) Table Qiagen N.V. Company Details Table Qiagen N.V. Revenue in Cancer Tumor Profiling Business (2014-2019) (Million US$) Figure Qiagen N.V. Revenue Growth Rate in Cancer Tumor Profiling Business (2014-2019) Table Qiagen N.V. Recent Development Table Roche Molecular Systems Inc. Company Details Table Roche Molecular Systems Inc. Revenue in Cancer Tumor Profiling Business (2014-2019)(Million US$) Figure Roche Molecular Systems Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2014-2019) Table Roche Molecular Systems Inc. Recent Development Table Abott Molecular Company Details Table Abott Molecular Revenue in Cancer Tumor Profiling Business (2014-2019)(Million US$) Figure Abott Molecular Revenue Growth Rate in Cancer Tumor Profiling Business (2014-2019) Table Abott Molecular Recent Development Table Illumina Inc. Company Details Table Illumina Inc. Revenue in Cancer Tumor Profiling Business (2014-2019)(Million US$) Figure Illumina Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2014-2019) Table Illumina Inc. Recent Development Table NeoGenomics Laboratories Company Details Table NeoGenomics Laboratories Revenue in Cancer Tumor Profiling Business (2014-2019)(Million US$) Figure NeoGenomics Laboratories Revenue Growth Rate in Cancer Tumor Profiling Business (2014-2019) Table NeoGenomics Laboratories Recent Development Table HTG Molecular Diagnostic Company Details Table HTG Molecular Diagnostic Revenue in Cancer Tumor Profiling Business (2014-2019)(Million US$) Figure HTG Molecular Diagnostic Revenue Growth Rate in Cancer Tumor Profiling Business (2014-2019) Table HTG Molecular Diagnostic Recent Development Table Genomic Health Inc. Company Details Table Genomic Health Inc. Revenue in Cancer Tumor Profiling Business (2014-2019)(Million US$) Figure Genomic Health Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2014-2019) Table Genomic Health Inc. Recent Development Table Hologic Gen-Probe Company Details Table Hologic Gen-Probe Revenue in Cancer Tumor Profiling Business (2014-2019)(Million US$) Figure Hologic Gen-Probe Revenue Growth Rate in Cancer Tumor Profiling Business (2014-2019) Table Hologic Gen-Probe Recent Development Table BD Biosciences Company Details Table BD Biosciences Revenue in Cancer Tumor Profiling Business (2014-2019)(Million US$) Figure BD Biosciences Revenue Growth Rate in Cancer Tumor Profiling Business (2014-2019) Table BD Biosciences Recent Development Table Siemens Healthineers Company Details Table Siemens Healthineers Revenue in Cancer Tumor Profiling Business (2014-2019)(Million US$) Figure Siemens Healthineers Revenue Growth Rate in Cancer Tumor Profiling Business (2014-2019) Table Siemens Healthineers Recent Development Table Claris Life Sciences Company Details Table Personal Genome Diagnostics, Inc. Company Details Table Perthera, Inc. Company Details Table Foundation Medicine, Inc Company Details Table V., Strand Company Details Table ApoCell Company Details Table Contextual Genomics Company Details Table Agendia Company Details Table GenScript Company Details Table Global Cancer Tumor Profiling Market Size by Regions (Million US$) 2019-2025 Figure Global Cancer Tumor Profiling Market Size Share by Regions (2019-2025) Figure Global Cancer Tumor Profiling Market Size Share by Regions in 2025 Figure United States Cancer Tumor Profiling Market Size Forecast (2019-2025)(Million USD) Figure Europe Cancer Tumor Profiling Market Size Forecast (2019-2025)(Million USD) Figure China Cancer Tumor Profiling Market Size Forecast (2019-2025)(Million USD) Figure Japan Cancer Tumor Profiling Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Cancer Tumor Profiling Market Size Forecast (2019-2025)(Million USD) Figure India Cancer Tumor Profiling Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Cancer Tumor Profiling Market Size Forecast (2019-2025)(Million USD) Table Global Cancer Tumor Profiling Market Size by Product (2019-2025) (Million US$) Figure Global Cancer Tumor Profiling Market Size by Product (2019-2025) Figure Global Cancer Tumor Profiling Market Size by Product in 2025 Table Global Cancer Tumor Profiling Market Size by Application (2019-2025) (Million US$) Figure Global Cancer Tumor Profiling Market Size by Application (2019-2025) Figure Global Cancer Tumor Profiling Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Qiagen N.V. Roche Molecular Systems Inc. Abott Molecular Illumina Inc. NeoGenomics Laboratories HTG Molecular Diagnostic Genomic Health Inc. Hologic Gen-Probe BD Biosciences Siemens Healthineers Claris Life Sciences Personal Genome Diagnostics, Inc. Perthera, Inc. Foundation Medicine, Inc V., Strand ApoCell Contextual Genomics Agendia GenScript